The North America acarbose API market is driven by the region’s established pharmaceutical sector and continued need for diabetes-management medicines. The US represents the leading market in the region, while regulatory requirements, API quality standards, and diversified pharmaceutical supply networks are shaping opportunities for manufacturers and suppliers. The acarbose API market...